Intracellular trafficking and cellular uptake mechanism of mPEG-PLGA-PLL and mPEG-PLGA-PLL-Gal nanoparticles for targeted delivery to hepatomas
Authors:
- Yanming SunYSYanming Sun
- Qi WangQWQi Wang
- Ying SunYSYing Sun
- He LiHLHe Li
- Yourong DuanYDYourong Duan
- 1 January 2014
- journal article
- Published by Elsevier in Biomaterials
- Vol. 35 (2) , 760-770
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81272568, 81101738)
- National 973 Basic Research Program of China (2010CB529902)
- Science and Technology Commission of Shanghai (13430722200)
- Shanghai Municipal Education Commission (14YZ029)
- Shanghai Jiao Tong University (YG2011MS53)
- Scientific Project of Shanghai Municipal Health Bureau (20114168)
- Science and Technology Commission of Shanghai Municipality (114119a3300)
- Fund of Shanghai Jiao Tong University School of Medicine (12XJ10079)
This publication has 36 references indexed in Scilit:
- Toxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in miceBiomaterials, 2013
- Intracellular trafficking mechanism, from intracellular uptake to extracellular efflux, for phospholipid/cholesterol liposomesBiomaterials, 2012
- Tumor-targeting multi-functional nanoparticles for theragnosis: New paradigm for cancer therapyAdvanced Drug Delivery Reviews, 2012
- Nanoparticle Delivery of Cancer DrugsAnnual Review of Medicine, 2012
- Design of polymeric nanoparticles for biomedical delivery applicationsChemical Society Reviews, 2012
- The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapyChemical Society Reviews, 2012
- Dynamic Colocalization Microscopy To Characterize Intracellular Trafficking of NanomedicinesACS Nano, 2011
- Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studiesNano Today, 2011
- Clinical Developments in Nanotechnology for Cancer TherapyPharmaceutical Research, 2010
- Nanoparticle therapeutics: an emerging treatment modality for cancerNature Reviews Drug Discovery, 2008